e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Highlights in respiratory epidemiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Co-morbidity is the main cost driver among COPD-subjects
S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden)
Source:
International Congress 2014 – Highlights in respiratory epidemiology
Session:
Highlights in respiratory epidemiology
Session type:
Oral Presentation
Number:
4439
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden). Co-morbidity is the main cost driver among COPD-subjects. Eur Respir J 2014; 44: Suppl. 58, 4439
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Co-morbidities of COPD in primary care
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Comorbidities and COPD severity: The French Palomb cohort
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Comorbidity at COPD - is actual problem of pulmonology
Source: International Congress 2014 – Predictors
Year: 2014
Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013
COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Comorbidity level in asthma patients
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Gender difference in asthma; symptoms, risk factors, comorbidities and emergency visits
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Comorbidity and some issues of cardiovascular disorders in disabled asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept